Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy: a multicenter study of the Arbeitsgemeinschaft Internistische Onko
about
Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and NeckSecond-line treatment of recurrent HNSCC: tumor debulking in combination with high-dose-rate brachytherapy and a simultaneous cetuximab-paclitaxel protocol.Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancerUpdate of cetuximab for non-melanoma skin cancer.Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib.Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013.TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO).Palliative treatment standards for head and neck squamous cell carcinoma : Survey of clinical routine in German-speaking countries.PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.
P2860
Q33650470-0D06634C-A88C-4CD5-8C95-44ACE6882A1DQ36480951-D4C3E808-EB48-4E8A-BA9A-1CD7A663FBF3Q37232854-E0052FB3-E9F8-4023-8E07-B22D349E0DA7Q38175499-2D3800D4-9138-4A6A-BA20-378B0B24D715Q38194548-AD145F95-9316-447D-B479-C431502A561AQ38196452-AA324B1B-E59A-4F73-82E8-7549AFB2D169Q38388694-F15196FE-0DC3-4CB5-BF63-18A447B4EAABQ39684719-E6C088C1-BC86-416D-8130-6EC5B45C427DQ54227938-A0DC15C8-E090-4A99-A6DB-4CF45235394C
P2860
Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy: a multicenter study of the Arbeitsgemeinschaft Internistische Onko
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Phase II study of cetuximab in ...... meinschaft Internistische Onko
@en
Phase II study of cetuximab in ...... meinschaft Internistische Onko
@nl
type
label
Phase II study of cetuximab in ...... meinschaft Internistische Onko
@en
Phase II study of cetuximab in ...... meinschaft Internistische Onko
@nl
prefLabel
Phase II study of cetuximab in ...... meinschaft Internistische Onko
@en
Phase II study of cetuximab in ...... meinschaft Internistische Onko
@nl
P2093
P2860
P356
P1433
P1476
Phase II study of cetuximab in ...... chaft Internistische Onkologie
@en
P2093
A Matzdorff
B Hennemann
F Weissinger
M Knoedler
M Schroeder
T C Gauler
U Keilholz
V Gruenwald
W Eberhardt
P2860
P304
P356
10.1159/000345453
P577
2013-02-26T00:00:00Z